BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

480 related articles for article (PubMed ID: 17959804)

  • 1. Stress-induced p38 mitogen-activated protein kinase activation mediates kappa-opioid-dependent dysphoria.
    Bruchas MR; Land BB; Aita M; Xu M; Barot SK; Li S; Chavkin C
    J Neurosci; 2007 Oct; 27(43):11614-23. PubMed ID: 17959804
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Kappa Opioid Receptor-Induced Aversion Requires p38 MAPK Activation in VTA Dopamine Neurons.
    Ehrich JM; Messinger DI; Knakal CR; Kuhar JR; Schattauer SS; Bruchas MR; Zweifel LS; Kieffer BL; Phillips PE; Chavkin C
    J Neurosci; 2015 Sep; 35(37):12917-31. PubMed ID: 26377476
    [TBL] [Abstract][Full Text] [Related]  

  • 3. p38 mitogen-activated protein kinase activation in amygdala mediates κ opioid receptor agonist U50,488H-induced conditioned place aversion.
    Zan GY; Wang Q; Wang YJ; Chen JC; Wu X; Yang CH; Chai JR; Li M; Liu Y; Hu XW; Shu XH; Liu JG
    Neuroscience; 2016 Apr; 320():122-8. PubMed ID: 26826330
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sciatic nerve ligation-induced proliferation of spinal cord astrocytes is mediated by kappa opioid activation of p38 mitogen-activated protein kinase.
    Xu M; Bruchas MR; Ippolito DL; Gendron L; Chavkin C
    J Neurosci; 2007 Mar; 27(10):2570-81. PubMed ID: 17344394
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Kappa opioid receptor activation of p38 MAPK is GRK3- and arrestin-dependent in neurons and astrocytes.
    Bruchas MR; Macey TA; Lowe JD; Chavkin C
    J Biol Chem; 2006 Jun; 281(26):18081-9. PubMed ID: 16648139
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Estrogen Regulation of GRK2 Inactivates Kappa Opioid Receptor Signaling Mediating Analgesia, But Not Aversion.
    Abraham AD; Schattauer SS; Reichard KL; Cohen JH; Fontaine HM; Song AJ; Johnson SD; Land BB; Chavkin C
    J Neurosci; 2018 Sep; 38(37):8031-8043. PubMed ID: 30076211
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ligand directed signaling differences between rodent and human κ-opioid receptors.
    Schattauer SS; Miyatake M; Shankar H; Zietz C; Levin JR; Liu-Chen LY; Gurevich VV; Rieder MJ; Chavkin C
    J Biol Chem; 2012 Dec; 287(50):41595-607. PubMed ID: 23086943
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Activation of the kappa opioid receptor in the dorsal raphe nucleus mediates the aversive effects of stress and reinstates drug seeking.
    Land BB; Bruchas MR; Schattauer S; Giardino WJ; Aita M; Messinger D; Hnasko TS; Palmiter RD; Chavkin C
    Proc Natl Acad Sci U S A; 2009 Nov; 106(45):19168-73. PubMed ID: 19864633
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Repeated swim stress induces kappa opioid-mediated activation of extracellular signal-regulated kinase 1/2.
    Bruchas MR; Xu M; Chavkin C
    Neuroreport; 2008 Sep; 19(14):1417-22. PubMed ID: 18766023
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The dysphoric component of stress is encoded by activation of the dynorphin kappa-opioid system.
    Land BB; Bruchas MR; Lemos JC; Xu M; Melief EJ; Chavkin C
    J Neurosci; 2008 Jan; 28(2):407-14. PubMed ID: 18184783
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reactive oxygen species (ROS) generation is stimulated by κ opioid receptor activation through phosphorylated c-Jun N-terminal kinase and inhibited by p38 mitogen-activated protein kinase (MAPK) activation.
    Schattauer SS; Bedini A; Summers F; Reilly-Treat A; Andrews MM; Land BB; Chavkin C
    J Biol Chem; 2019 Nov; 294(45):16884-16896. PubMed ID: 31575661
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nalfurafine is a G-protein biased agonist having significantly greater bias at the human than rodent form of the kappa opioid receptor.
    Schattauer SS; Kuhar JR; Song A; Chavkin C
    Cell Signal; 2017 Apr; 32():59-65. PubMed ID: 28088389
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tyrosine phosphorylation of Kir3 following kappa-opioid receptor activation of p38 MAPK causes heterologous desensitization.
    Clayton CC; Xu M; Chavkin C
    J Biol Chem; 2009 Nov; 284(46):31872-81. PubMed ID: 19773548
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Signaling events initiated by kappa opioid receptor activation: quantification and immunocolocalization using phospho-selective KOR, p38 MAPK, and K(IR) 3.1 antibodies.
    Lemos JC; Roth CA; Chavkin C
    Methods Mol Biol; 2011; 717():197-219. PubMed ID: 21370032
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The long-term effects of stress and kappa opioid receptor activation on conditioned place aversion in male and female California mice.
    Laman-Maharg AR; Copeland T; Sanchez EO; Campi KL; Trainor BC
    Behav Brain Res; 2017 Aug; 332():299-307. PubMed ID: 28625549
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prior activation of kappa opioid receptors by U50,488 mimics repeated forced swim stress to potentiate cocaine place preference conditioning.
    McLaughlin JP; Land BB; Li S; Pintar JE; Chavkin C
    Neuropsychopharmacology; 2006 Apr; 31(4):787-94. PubMed ID: 16123754
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Endogenous kappa opioid activation mediates stress-induced deficits in learning and memory.
    Carey AN; Lyons AM; Shay CF; Dunton O; McLaughlin JP
    J Neurosci; 2009 Apr; 29(13):4293-300. PubMed ID: 19339623
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Stress produces aversion and potentiates cocaine reward by releasing endogenous dynorphins in the ventral striatum to locally stimulate serotonin reuptake.
    Schindler AG; Messinger DI; Smith JS; Shankar H; Gustin RM; Schattauer SS; Lemos JC; Chavkin NW; Hagan CE; Neumaier JF; Chavkin C
    J Neurosci; 2012 Dec; 32(49):17582-96. PubMed ID: 23223282
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Upregulation of dynorphin/kappa opioid receptor system in the dorsal hippocampus contributes to morphine withdrawal-induced place aversion.
    Chen Y; Wang CY; Zan GY; Yao SY; Deng YZ; Shu XL; Wu WW; Ma Y; Wang YJ; Yu CX; Liu JG
    Acta Pharmacol Sin; 2023 Mar; 44(3):538-545. PubMed ID: 36127507
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of RGS12 in the differential regulation of kappa opioid receptor-dependent signaling and behavior.
    Gross JD; Kaski SW; Schmidt KT; Cogan ES; Boyt KM; Wix K; Schroer AB; McElligott ZA; Siderovski DP; Setola V
    Neuropsychopharmacology; 2019 Sep; 44(10):1728-1741. PubMed ID: 31141817
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.